Database

Startups

Main Industry
Biotechnology
Main Product/Service
Xgene’s key products are clinical-stage analgesic candidates, including oral dual‑mechanism conjugates and topical gels, designed to enhance efficacy and safety through multimodal mechanisms and high target specificity.
Founded Year
2015
Unified Business No.
42836798
Status
Active
Number of Employees
0
Total Paid-in Capital
100,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
Xgene Pharmaceutical Inc. is an innovative biotech company focused on neurological disorders and pain management, using proprietary linker technology to develop dual‑acting prodrugs aimed at safer and more effective next‑generation analgesic therapies.



More ↓

Similar Companies

TAHO PHARMACEUTICALS LTD.

1. TAH4411 Ondansetron ODF
2. TAH3311 Apixaban Oral Film
3. TAH3341 Apixaban Oral Extend Release Film
4. TAH2211 Buprenorphine/Naloxone Sublingual Film
5. TAH2231 Naloxone Buccal Film
6. TAH9922 Atomoxetine Oral Liquid
7. TAH9901 Methylphenidate Patch

BIONOVAX CORP.

1. Heparin API
2. Water Essence – GAGs product

Taiwan Universe BioMedicine Inc.

Main Product
Innovative platform of enterovirus and influenza VLP vaccines
Promising option to combat viruses mutation
Provide a broad-spectrum prevention with better immunogenicity
Enable faster scaling-up

ImmunAdd Inc.

ImmunAdd develops innovative and practical solutions for human health. We aim to harness the immune system to create next-generation immunotherapeutics for the treatment of infectious diseases and cancer. Our next-generation adjuvants provide better immun